Migraine Drugs Market 2028 By Product Type, Route of Administration, Distribution Channel, and Geography | The Insight Partners

Migraine Drugs Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Product Type (Acute Migraine Treatment and Preventive Migraine Treatment); Route of Administration (Injection, Oral and Other Routes of Administration); Distribution Channel (Hospitals Based Pharmacies and Online Pharmacies, Retail Pharmacies), and Geography

Report Code: TIPRE00008682 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Migraine Drugs Market - By Product Type
1.3.2 Migraine Drugs Market - By Route of Administration
1.3.3 Migraine Drugs Market - By Distribution Channel
1.3.4 Migraine Drugs Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. MIGRAINE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. MIGRAINE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. MIGRAINE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. MIGRAINE DRUGS - GLOBAL MARKET OVERVIEW
6.2. MIGRAINE DRUGS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. MIGRAINE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ACUTE MIGRAINE TREATMENT
7.3.1. Overview
7.3.2. Acute Migraine Treatment Market Forecast and Analysis
7.3.3. Analgesic Market
7.3.3.1. Overview
7.3.3.2. Analgesic Market Forecast and Analysis
7.3.4. Ergotamine Market
7.3.4.1. Overview
7.3.4.2. Ergotamine Market Forecast and Analysis
7.3.5. Triptans Market
7.3.5.1. Overview
7.3.5.2. Triptans Market Forecast and Analysis
7.4. PREVENTIVE MIGRAINE TREATMENT
7.4.1. Overview
7.4.2. Preventive Migraine Treatment Market Forecast and Analysis
7.4.3. Anti-Convulsants Market
7.4.3.1. Overview
7.4.3.2. Anti-Convulsants Market Forecast and Analysis
7.4.4. Antidepressants Market
7.4.4.1. Overview
7.4.4.2. Antidepressants Market Forecast and Analysis
7.4.5. Anti-Serotonergic Drugs Market
7.4.5.1. Overview
7.4.5.2. Anti-Serotonergic Drugs Market Forecast and Analysis
7.4.6. Beta Blockers Market
7.4.6.1. Overview
7.4.6.2. Beta Blockers Market Forecast and Analysis
7.4.7. Calcium Channel Blockers Market
7.4.7.1. Overview
7.4.7.2. Calcium Channel Blockers Market Forecast and Analysis
7.4.8. Other Preventive Migraine Treatments Market
7.4.8.1. Overview
7.4.8.2. Other Preventive Migraine Treatments Market Forecast and Analysis
8. MIGRAINE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. INJECTION
8.3.1. Overview
8.3.2. Injection Market Forecast and Analysis
8.4. ORAL
8.4.1. Overview
8.4.2. Oral Market Forecast and Analysis
8.5. OTHER ROUTES OF ADMINISTRATION
8.5.1. Overview
8.5.2. Other Routes of Administration Market Forecast and Analysis
9. MIGRAINE DRUGS MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS BASED PHARMACIES
9.3.1. Overview
9.3.2. Hospitals Based Pharmacies Market Forecast and Analysis
9.4. ONLINE PHARMACIES
9.4.1. Overview
9.4.2. Online Pharmacies Market Forecast and Analysis
9.5. RETAIL PHARMACIES
9.5.1. Overview
9.5.2. Retail Pharmacies Market Forecast and Analysis
10. MIGRAINE DRUGS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Migraine Drugs Market Overview
10.1.2 North America Migraine Drugs Market Forecasts and Analysis
10.1.3 North America Migraine Drugs Market Forecasts and Analysis - By Product Type
10.1.4 North America Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Migraine Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Migraine Drugs Market
10.1.6.1.1 United States Migraine Drugs Market by Product Type
10.1.6.1.2 United States Migraine Drugs Market by Route of Administration
10.1.6.1.3 United States Migraine Drugs Market by Distribution Channel
10.1.6.2 Canada Migraine Drugs Market
10.1.6.2.1 Canada Migraine Drugs Market by Product Type
10.1.6.2.2 Canada Migraine Drugs Market by Route of Administration
10.1.6.2.3 Canada Migraine Drugs Market by Distribution Channel
10.1.6.3 Mexico Migraine Drugs Market
10.1.6.3.1 Mexico Migraine Drugs Market by Product Type
10.1.6.3.2 Mexico Migraine Drugs Market by Route of Administration
10.1.6.3.3 Mexico Migraine Drugs Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Migraine Drugs Market Overview
10.2.2 Europe Migraine Drugs Market Forecasts and Analysis
10.2.3 Europe Migraine Drugs Market Forecasts and Analysis - By Product Type
10.2.4 Europe Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Migraine Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Migraine Drugs Market
10.2.6.1.1 Germany Migraine Drugs Market by Product Type
10.2.6.1.2 Germany Migraine Drugs Market by Route of Administration
10.2.6.1.3 Germany Migraine Drugs Market by Distribution Channel
10.2.6.2 France Migraine Drugs Market
10.2.6.2.1 France Migraine Drugs Market by Product Type
10.2.6.2.2 France Migraine Drugs Market by Route of Administration
10.2.6.2.3 France Migraine Drugs Market by Distribution Channel
10.2.6.3 Italy Migraine Drugs Market
10.2.6.3.1 Italy Migraine Drugs Market by Product Type
10.2.6.3.2 Italy Migraine Drugs Market by Route of Administration
10.2.6.3.3 Italy Migraine Drugs Market by Distribution Channel
10.2.6.4 Spain Migraine Drugs Market
10.2.6.4.1 Spain Migraine Drugs Market by Product Type
10.2.6.4.2 Spain Migraine Drugs Market by Route of Administration
10.2.6.4.3 Spain Migraine Drugs Market by Distribution Channel
10.2.6.5 United Kingdom Migraine Drugs Market
10.2.6.5.1 United Kingdom Migraine Drugs Market by Product Type
10.2.6.5.2 United Kingdom Migraine Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Migraine Drugs Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Migraine Drugs Market Overview
10.3.2 Asia-Pacific Migraine Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Migraine Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Migraine Drugs Market
10.3.6.1.1 Australia Migraine Drugs Market by Product Type
10.3.6.1.2 Australia Migraine Drugs Market by Route of Administration
10.3.6.1.3 Australia Migraine Drugs Market by Distribution Channel
10.3.6.2 China Migraine Drugs Market
10.3.6.2.1 China Migraine Drugs Market by Product Type
10.3.6.2.2 China Migraine Drugs Market by Route of Administration
10.3.6.2.3 China Migraine Drugs Market by Distribution Channel
10.3.6.3 India Migraine Drugs Market
10.3.6.3.1 India Migraine Drugs Market by Product Type
10.3.6.3.2 India Migraine Drugs Market by Route of Administration
10.3.6.3.3 India Migraine Drugs Market by Distribution Channel
10.3.6.4 Japan Migraine Drugs Market
10.3.6.4.1 Japan Migraine Drugs Market by Product Type
10.3.6.4.2 Japan Migraine Drugs Market by Route of Administration
10.3.6.4.3 Japan Migraine Drugs Market by Distribution Channel
10.3.6.5 South Korea Migraine Drugs Market
10.3.6.5.1 South Korea Migraine Drugs Market by Product Type
10.3.6.5.2 South Korea Migraine Drugs Market by Route of Administration
10.3.6.5.3 South Korea Migraine Drugs Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Migraine Drugs Market Overview
10.4.2 Middle East and Africa Migraine Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Migraine Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Migraine Drugs Market
10.4.6.1.1 South Africa Migraine Drugs Market by Product Type
10.4.6.1.2 South Africa Migraine Drugs Market by Route of Administration
10.4.6.1.3 South Africa Migraine Drugs Market by Distribution Channel
10.4.6.2 Saudi Arabia Migraine Drugs Market
10.4.6.2.1 Saudi Arabia Migraine Drugs Market by Product Type
10.4.6.2.2 Saudi Arabia Migraine Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Migraine Drugs Market by Distribution Channel
10.4.6.3 U.A.E Migraine Drugs Market
10.4.6.3.1 U.A.E Migraine Drugs Market by Product Type
10.4.6.3.2 U.A.E Migraine Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Migraine Drugs Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Migraine Drugs Market Overview
10.5.2 South and Central America Migraine Drugs Market Forecasts and Analysis
10.5.3 South and Central America Migraine Drugs Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Migraine Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Migraine Drugs Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Migraine Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Migraine Drugs Market
10.5.6.1.1 Brazil Migraine Drugs Market by Product Type
10.5.6.1.2 Brazil Migraine Drugs Market by Route of Administration
10.5.6.1.3 Brazil Migraine Drugs Market by Distribution Channel
10.5.6.2 Argentina Migraine Drugs Market
10.5.6.2.1 Argentina Migraine Drugs Market by Product Type
10.5.6.2.2 Argentina Migraine Drugs Market by Route of Administration
10.5.6.2.3 Argentina Migraine Drugs Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. MIGRAINE DRUGS MARKET, KEY COMPANY PROFILES
12.1. ALDER BIOPHARMACEUTICALS INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLERGAN
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ASTRAZENECA
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. EISAI CO., LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ELI LILLY AND COMPANY
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GLAXOSMITHKLINE PLC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. H. LUNDBECK A/S
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TEVA PHARMACEUTICAL INDUSTRIES LTD.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. ALDER BIOPHARMACEUTICALS INC.
2. Allergan
3. AstraZeneca
4. Eisai Co., Ltd.
5. Eli Lilly and Company
6. GlaxoSmithKline plc.
7. H. Lundbeck A/S
8. Novartis AG
9. Pfizer Inc.
10. Teva Pharmaceutical Industries Ltd
TIPRE00008682
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount